Erlotinib Active Not Recruiting Phase 1 Trials for Cancer, Advanced / Tumors, Solid Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00543504Bevacizumab in Multiple Phase I Combinations
NCT01197170Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance